Oxidized lipids as molecular biomarkers in carotid in-stent restenosis: mechanisms and clinical implications - Takeaways - MDSpire

Oxidized lipids as molecular biomarkers in carotid in-stent restenosis: mechanisms and clinical implications

  • By

  • Qiao Chen

  • Haifeng Shao

  • Zhaohui He

  • Ping Ni

  • Nengwei Yu

  • Binghu Li

  • Suping Li

  • May 4, 2026

  • 0 min

Share

  • 1

    Carotid artery stenting (CAS) is an effective treatment for carotid artery stenosis but has a 10–30% risk of in-stent restenosis (ISR) within the first year.

  • 2

    Oxidative stress and lipid peroxidation are key mechanisms driving neointimal hyperplasia and vascular remodeling in ISR following stent implantation.

  • 3

    Specific oxidized lipid species, such as oxidized phospholipids and oxidized low-density lipoprotein, are associated with ISR risk and severity.

  • 4

    Understanding the role of oxidized lipids offers potential for improved risk stratification and targeted therapeutic interventions in ISR.

  • 5

    Future research should focus on validating oxidized lipid biomarkers and developing strategies to target oxidized lipid pathways to prevent ISR.

Original Source(s)

Related Content